ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,628, issued on Jan. 13, was assigned to SHANGHAI ZHEYE BIOTECHNOLOGY Co. LTD. (Shanghai).

"Aryl glucoside derivative and use thereof in drug" was invented by Fengtian Du (Shanghai), Haibo Wang (Shanghai) and Qiang Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound inhibiting a sodium-glucose cotransporter 1, and a pharmaceutically acceptable salt and a stereoisomer thereof. The compound is used in a pharmaceutical composition. Also disclosed are methods for preparing and using the pharmaceutical composition, and an application in preparing a drug and a composition of the compound for treating and improving diabetes cardio-vasc...